Research and development expenses
| (€‘000) | For the year ended December 31, | |||||||||||
| 2017 | 2016 | 2015 | ||||||||||
|
Salaries |
7,007 | 8,160 | 5,785 | |||||||||
|
Share-based payments |
862 | — | — | |||||||||
|
Travel and living |
359 | 577 | 168 | |||||||||
|
Preclinical studies |
1,995 | 4,650 | 2,398 | |||||||||
|
Clinical studies |
3,023 | 4,468 | 6,723 | |||||||||
|
Raw materials & consumables |
1,825 | — | — | |||||||||
|
Delivery systems |
430 | 964 | 173 | |||||||||
|
Consulting fees |
1,522 | 791 | 1,842 | |||||||||
|
External collaborations |
885 | — | — | |||||||||
|
IP filing and maintenance fees |
513 | 799 | 763 | |||||||||
|
Scale-up & automation |
1,892 | 4,164 | 642 | |||||||||
|
Rent and utilities |
371 | 939 | 1,045 | |||||||||
|
Depreciation and amortization |
1,488 | 1,345 | 1,033 | |||||||||
|
Other costs |
735 | 817 | 2,196 | |||||||||
|
|
|
|
|
|
|
|||||||
|
Total Research and Development expenses |
22,908 | 27,675 | 22,767 | |||||||||
|
|
|
|
|
|
|
|||||||